Status:
COMPLETED
Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)
Lead Sponsor:
Javelin Pharmaceuticals
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)
Detailed Description
Subjects will participate in a two-period, single-sequence study to assess the effects of administration of a nasal corticosteroid, Nasonex (mometasone furoate), on the pharmacokinetics, safety and to...
Eligibility Criteria
Inclusion
- healthy adults
- nonsmoker
- no drug use
Exclusion
- nasal abnormalities
- airway abnormalities
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00662883
Start Date
November 1 2007
End Date
February 1 2008
Last Update
April 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baltimore, Maryland, United States, 21225